Responses
Plenary sessions
Plenary 1
IGCS19-0455
2 Exploratory analysis of postprogression and patient-centered outcomes in ariel3: a phase 3, randomized, placebo-controlled study of rucaparib maintenance treatment in patients with recurrent ovarian carcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.